SLI
2.082,98
PKT
+28,94
PKT
+1,41
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
07.11.19 | Zurich Insurance Outperform | RBC Capital Markets | |
07.11.19 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
07.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
07.11.19 | Roche buy | UBS AG | |
06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.11.19 | Holcim overweight | Morgan Stanley | |
04.11.19 | UBS buy | Goldman Sachs Group Inc. | |
04.11.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
01.11.19 | Swiss Re Sell | UBS AG | |
01.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
01.11.19 | Swiss Re Sector Perform | RBC Capital Markets | |
01.11.19 | UBS buy | Kepler Cheuvreux | |
01.11.19 | Swiss Re kaufen | Credit Suisse Group | |
31.10.19 | Swiss Re Sector Perform | RBC Capital Markets | |
31.10.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
31.10.19 | Swiss Re overweight | Barclays Capital | |
31.10.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
31.10.19 | Novartis Hold | Deutsche Bank AG | |
31.10.19 | UBS buy | Deutsche Bank AG | |
31.10.19 | Swiss Re Sell | UBS AG | |
31.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
30.10.19 | Holcim buy | Goldman Sachs Group Inc. | |
30.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
30.10.19 | UBS buy | Goldman Sachs Group Inc. | |
30.10.19 | UBS Equal weight | Barclays Capital | |
30.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
30.10.19 | UBS Equal weight | Barclays Capital | |
30.10.19 | UBS Equal-Weight | Morgan Stanley | |
30.10.19 | UBS Sector Perform | RBC Capital Markets | |
30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
30.10.19 | UBS buy | UBS AG | |
30.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
29.10.19 | Holcim Equal weight | Barclays Capital | |
29.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
28.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
26.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
25.10.19 | Novartis Underweight | Barclays Capital | |
25.10.19 | Holcim Neutral | UBS AG |